National Cancer Institute

at the National Institutes of Health

Find a Cancer Type

A	B	C	D	E	F	G	H	I
J	K	L	M	N	O	P	Q	R
S	T	U	V	W	X	Y	Z

NCI Vision & Priorities

image of NCI Director Harold E. Varmus, M.D.

The National Cancer Program

Popular Resources

NCI Dictionary of Cancer Terms
Cancer-related terms
NCI Drug Dictionary
Definitions, names, and links
NCI Publications
Order/download free booklets
Funding Opportunities
Research and training
NCI Funded Research Portfolio
Funding information reports
Advisory Boards and Groups
Information, meetings, reports
Español
Información en español

Two male technicians wearing white lab coats in a large room with multiple sequencing machines at The Genome Institute at Washington University in St. Louis.

Two More Cancer Genomes Are Sequenced

Two new studies from The Cancer Genome Atlas (TCGA) Research Network – one on acute myeloid leukemia (AML) and the other on endometrial cancer – represent the program's latest efforts to sequence the genomes of 20 major cancers. The studies offer insights into the molecular underpinnings of these cancers with the potential to improve treatment.

•	Endometrial and acute myeloid leukemia cancer genomes characterized
•	The Cancer Genome Atlas

Cups of tea, a man doing tai chi, acupuncture needles, a woman being massaged.

Complementary Therapies in Cancer Care

Complementary and alternative medicine (CAM) includes a wide variety of therapies, such as botanicals, nutritional products, and practices including acupuncture and yoga. These are used in addition to (complementary) or instead of (alternative) standard treatments, usually to help manage the symptoms of cancer.

•	Topics in Complementary and Alternative Therapies
•	Workbook: Talking about CAM with Health Care Providers
•	NCI's Complementary and Alternative Medicine portal

Provocative Questions Funding Available

Funding is available to researchers with bold approaches to 24 questions identified by the oncology community as part of NCI’s Provocative Questions initiative. Submit a letter of intent by May 20, 2013. Applications are due June 20, 2013.

•	View the list of questions and RFAs
•	About the Provocative Questions initiative

New Findings from The Cancer Genome Atlas
Complementary Therapies in Cancer Care
Provocative Questions Funding Available

Cancer Research News

Types of Cancer
	Common Cancer Types Bladder Cancer Breast Cancer Colon and Rectal Cancer Endometrial Cancer Kidney (Renal Cell) Cancer Leukemia Lung Cancer Melanoma Non-Hodgkin Lymphoma


	Pancreatic Cancer Prostate Cancer Thyroid Cancer All Cancer Types Cancers by Body Location/System Childhood Cancers Adolescents and Young Adults Women's Cancers

Clinical Trials
	Search for Clinical Trials What Is a Clinical Trial? Clinical Trial Results Learn About Clinical Trials

Research & Funding
	Funding Opportunities Training Opportunities Research Programs Sponsored by NCI Research at NCI

Cancer Statistics
	Find Cancer Statistics Statistical Tools and Data for Researchers

Cancer Topics
	What Is Cancer? Treatment Prevention, Genetics, Causes Screening and Testing Coping with Cancer Smoking Cancer Health Disparities NCI Fact Sheets Physician Data Query (PDQ®)

Follow Us:

Other Versions: Mobile | Español

NIH…Turning Discovery Into Health^®

National Cancer Institute

at the National Institutes of Health

Find a Cancer Type

NCI Vision & Priorities

Popular Resources

Two More Cancer Genomes Are Sequenced

Complementary Therapies in Cancer Care

Provocative Questions Funding Available

Two More Cancer Genomes Are Sequenced

Complementary Therapies in Cancer Care

Provocative Questions Funding Available

Cancer Research News

Types of Cancer

Clinical Trials

Research & Funding

Cancer Statistics

Cancer Topics